Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
In published research protocols, BPC-157 has been studied across a dosing range of 1-10 mcg/kg in animal models, with the majority of positive results observed at doses between 2-10 mcg/kg administered intraperitoneally or subcutaneously
Inhibit lipogenesis the metabolic process that forms fat (even from nonfat foods), which increases the amount of triglycerides in the body
However, due to the complexity of strain screening, the current fermentation level is still relatively low
Capturing the angel in angel dust: twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans
Biochem J 228:653660 Lensman M, Korzhevskii DE, Mourovets VO et al (2006) Intracerebroventricular administration of creatine protects against damage by global cerebral ischemia in rat